{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:23Z","timestamp":1786988123424,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.ejphar.2008.06.022","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T09:44:36Z","timestamp":1213263876000},"page":"212-216","source":"Crossref","is-referenced-by-count":27,"title":["Agmatine attenuates the disruptive effects of phencyclidine on prepulse inhibition"],"prefix":"10.1016","volume":"590","author":[{"given":"Erik","family":"P\u00e5lsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Fejgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Wass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Klamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.06.022_bib1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.135.9.1081","article-title":"Phencyclidine-induced psychosis","volume":"135","author":"Allen","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2008.06.022_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1196\/annals.1304.014","article-title":"Is agmatine an endogenous anxiolytic\/antidepressant agent?","volume":"1009","author":"Aricioglu","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2008.06.022_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002130100705","article-title":"Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase","volume":"155","author":"Bird","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.06.022_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1469-8986.1978.tb01390.x","article-title":"Prestimulus effects on human startle reflex in normals and schizophrenics","volume":"15","author":"Braff","year":"1978","journal-title":"Psychophysiology"},{"key":"10.1016\/j.ejphar.2008.06.022_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/schbul\/19.2.233","article-title":"Information processing and attention dysfunctions in schizophrenia","volume":"19","author":"Braff","year":"1993","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.ejphar.2008.06.022_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0278-5846(97)00184-X","article-title":"Effects of phencyclidine (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice","volume":"22","author":"Curzon","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2008.06.022_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/mol.59.1.24","article-title":"Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme","volume":"59","author":"Demady","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.06.022_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1196\/annals.1300.008","article-title":"The NMDA receptor hypofunction model of psychosis","volume":"1003","author":"Farber","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2008.06.022_bib9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1203\/00006450-200210000-00023","article-title":"Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats","volume":"52","author":"Feng","year":"2002","journal-title":"Pediatr. Res."},{"issue":"Pt 1","key":"10.1016\/j.ejphar.2008.06.022_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj3160247","article-title":"Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine","volume":"316","author":"Galea","year":"1996","journal-title":"Biochem J."},{"key":"10.1016\/j.ejphar.2008.06.022_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1469-8986.1975.tb01284.x","article-title":"The more or less startling effects of weak prestimulation","volume":"12","author":"Graham","year":"1975","journal-title":"Psychophysiology"},{"key":"10.1016\/j.ejphar.2008.06.022_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine: metabolic pathway and spectrum of activity in brain","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2008.06.022_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1037\/0033-295X.87.2.175","article-title":"Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input","volume":"87","author":"Hoffman","year":"1980","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.ejphar.2008.06.022_bib14","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-4159.2005.03544.x","article-title":"Expression of arginine decarboxylase in brain regions and neuronal cells","volume":"96","author":"Iyo","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2008.06.022_bib15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2008.06.022_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2008.06.022_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002130050280","article-title":"Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat","volume":"131","author":"Johansson","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.06.022_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s002130100783","article-title":"The nitric oxide synthase inhibitor, L-NAME, blocks phencyclidine-induced disruption of prepulse inhibition in mice","volume":"156","author":"Klamer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.ejphar.2008.06.022_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1742-7843.2004.pto940203.x","article-title":"Phencyclidine-induced behaviours in mice prevented by methylen blue","volume":"94","author":"Klamer","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2008.06.022_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-004-2051-z","article-title":"Activation of a nitric oxide sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition","volume":"179","author":"Klamer","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.06.022_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbr.2005.01.008","article-title":"Antagonism of the nitric oxide synthase inhibitor, L-NAME, of the effects of phencyclidine on latent inhibition in taste aversion conditioning","volume":"161","author":"Klamer","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2008.06.022_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbr.2004.10.006","article-title":"Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat","volume":"159","author":"Klamer","year":"2005","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.ejphar.2008.06.022_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bbr.2007.11.013","article-title":"Antidepressant-like effect of agmatine is not mediated by serotonin","volume":"188","author":"Krass","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2008.06.022_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-4328(02)00326-1","article-title":"Agmatine induces anxiolysis in the elevated plus maze task in adult rats","volume":"141","author":"Lavinsky","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2008.06.022_bib25","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.7906055","article-title":"Agmatine: an endogenous clonidine-displacing substance in the brain","volume":"263","author":"Li","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2008.06.022_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(03)01735-7","article-title":"Antidepressant-like effect of agmatine and its possible mechanism","volume":"469","author":"Li","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.06.022_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug-sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.ejphar.2008.06.022_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.2044-8341.1961.tb00936.x","article-title":"Disorders of attention and perception in early schizophrenia","volume":"34","author":"McGhie","year":"1961","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.ejphar.2008.06.022_bib29","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/sj.bjp.0702679","article-title":"Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor","volume":"127","author":"Olmos","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.06.022_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(97)01200-6","article-title":"Regional localization of agmatine in the rat brain: an immunocytochemical study","volume":"787","author":"Otake","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.06.022_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002130050333","article-title":"Inbred strain differences in prepulse inhibition of the mouse startle response","volume":"132","author":"Paylor","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.06.022_bib32","first-page":"581","article-title":"Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors","volume":"272","author":"Piletz","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.06.022_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","article-title":"Is agmatine a novel neurotransmitter in brain?","volume":"21","author":"Reis","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2008.06.022_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3940(98)00466-2","article-title":"Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells","volume":"250","author":"Reis","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2008.06.022_bib35","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/sj.bjp.0704556","article-title":"Effect of agmatine on locus coeruleus neuron activity: possible involvement of nitric oxide","volume":"135","author":"Ruiz-Durantez","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.06.022_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/j.1875-9114.1996.tb02920.x","article-title":"A review of NMDA receptors and the phencyclidine model of schizophrenia","volume":"16","author":"Thornberg","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2008.06.022_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbr.2006.07.003","article-title":"Phencyclidine affects memory in a nitric oxide-dependent manner: working and reference memory","volume":"174","author":"Wass","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2008.06.022_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0893-133X(98)00008-6","article-title":"Nitric oxide synthase inhibitors attenuate phencyclidine-induced disruption of prepulse inhibition","volume":"19","author":"Wiley","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2008.06.022_bib39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3565(24)37988-1","article-title":"Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons","volume":"288","author":"Yang","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.06.022_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001756-200203250-00005","article-title":"Agmatine produces antidepressant-like effects in two models of depression in mice","volume":"13","author":"Zomkowski","year":"2002","journal-title":"NeuroReport"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908006456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908006456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T12:48:45Z","timestamp":1738241325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908006456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":40,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0014299908006456"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.06.022","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}